BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9112798)

  • 21. [Strongyloides stercoralis, an insidious oddity].
    Kager PA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(44):2249-50. PubMed ID: 8255320
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of strongyloides infections.
    Hanck C; Hatz C
    Gastroenterology; 2000 Dec; 119(6):1805-6. PubMed ID: 11187437
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of severe strongyloidiasis].
    Tumol'skaia NI; Mazmanian MV; Pliushcheva GL; Rogova LA
    Med Parazitol (Mosk); 2002; (1):50-2. PubMed ID: 12224270
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis.
    Pitisuttithum P; Supanaranond W; Chindanond D
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):735-8. PubMed ID: 9139386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strongyloidiasis associated with nephrotic syndrome.
    Mori S; Konishi T; Matsuoka K; Deguchi M; Ohta M; Mizuno O; Ueno T; Okinaka T; Nishimura Y; Ito N; Nakano T
    Intern Med; 1998 Jul; 37(7):606-10. PubMed ID: 9711888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.
    Schaffel R; Nucci M; Portugal R; Castro MB; Ferreira SB; Almeida L; Spector N; Pulcheri W
    Clin Infect Dis; 2000 Sep; 31(3):821-2. PubMed ID: 11017840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of pleuritis caused by strongyloides in a carrier of T-cell lymphoma virus type I (HTLV-I)].
    Oya H; Mori S; Tsuchihashi H; Kurono A; Mizoguchi A; Kawabata M; Arimura K; Osame M
    Nihon Kokyuki Gakkai Zasshi; 1998 Mar; 36(3):262-7. PubMed ID: 9656674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image of the month. Strongyloides stercoralis larvae.
    Hokama A; Adaniya H; Saito A
    Gastroenterology; 1998 Jan; 114(1):6, 230. PubMed ID: 9428211
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary manifestations of strongyloidiasis.
    Wehner JH; Kirsch CM
    Semin Respir Infect; 1997 Jun; 12(2):122-9. PubMed ID: 9195677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An overview of Strongyloides stercoralis and its infections].
    Ardiç N
    Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Strongyloides stercoralis: risk factors for disseminated infection].
    Pardo Moreno G; Rodríguez Rodríguez R; Campillos Páez MT
    Med Clin (Barc); 2003 Nov; 121(17):662-4. PubMed ID: 14642229
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis.
    Bisoffi Z; Buonfrate D; Angheben A; Boscolo M; Anselmi M; Marocco S; Monteiro G; Gobbo M; Bisoffi G; Gobbi F
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1254. PubMed ID: 21814588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe anguilluliasis in a chronic haemodialysis patient].
    Hachim K; Mortajil F; Chakib A; Ramdani B; Zaid D
    Presse Med; 2005 Jan; 34(2 Pt 1):105-6. PubMed ID: 15687978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prurigo in a patient with intestinal strongyloidiasis.
    Albanese G; Venturi C; Galbiati G
    Int J Dermatol; 2001 Jan; 40(1):52-4. PubMed ID: 11277955
    [No Abstract]   [Full Text] [Related]  

  • 35. [Strongyloides stercoralis infection in patients with bronchial obstructive pathology].
    Cremades Romero MJ; Pellicer Ciscar C; Menéndez Villanueva R; Ricart Olmos C; Pastor-Guzmán A; Estellés Piera F; Igual Adell R; Gilabert Bonet MJ
    Arch Bronconeumol; 1997 Sep; 33(8):384-8. PubMed ID: 9376938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Strongyloidosis. Part VII. Epidemiology and prevention (2)].
    Soroczan W
    Wiad Parazytol; 2000; 46(3):345-64. PubMed ID: 16883689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strongyloides stercoralis infection: how to diagnose best?
    van der Feltz M; Slee PH; van Hees PA; Tersmette M
    Neth J Med; 1999 Sep; 55(3):128-31. PubMed ID: 10509071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Strongyloidosis. Part IX. Treatment].
    Soroczan W
    Wiad Parazytol; 2002; 48(2):173-96. PubMed ID: 16888940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment for chronic Strongyloides stercoralis infection: moderate-to-low evidence shows that ivermectin is more effective and tolerable than albendazole and thiabendazole, respectively.
    Buonfrate D; Gobbi F
    Evid Based Med; 2016 Jun; 21(3):102. PubMed ID: 27112446
    [No Abstract]   [Full Text] [Related]  

  • 40. Strongyloidiasis in patients at a comprehensive cancer center in the United States.
    Safdar A; Malathum K; Rodriguez SJ; Husni R; Rolston KV
    Cancer; 2004 Apr; 100(7):1531-6. PubMed ID: 15042689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.